Literature DB >> 30121836

Micronized palmitoylethanolamide reduces joint pain and glial cell activation.

Maria Lavinia Bartolucci1, Ida Marini1, Francesco Bortolotti1, Daniela Impellizzeri2, Rosanna Di Paola2, Giuseppe Bruschetta2, Rosalia Crupi2, Marco Portelli3, Angela Militi3, Giacomo Oteri3, Emanuela Esposito2, Salvatore Cuzzocrea4,5.   

Abstract

OBJECTIVE AND
DESIGN: Temporomandibular disorder (TMD) is a common painful condition in the temporomandibular joint (TMJ). Joint inflammation is believed to be a chief cause of pain in patients with TMD, through the release of pro-inflammatory cytokines that induce peripheral sensitization of nerve terminals followed by microglial stimulation. MATERIALS AND SUBJECT: TMJ was induced in rats with the injection of complete Freund's adjuvant (CFA) emulsion into the left TMJ capsule. TREATMENT: The present study would assess the effects of micronized palmitoylethanolamide (m-PEA) on glial activation and trigeminal hypersensitivity.
METHODS: Ten mg/kg m-PEA or corresponding vehicle was administered 1 h after CFA and mechanical allodynia and edema were evaluated at 24 and 72 h after CFA injection.
RESULTS: CFA-injected animals showed TMJ edema and ipsilateral mechanical allodynia accompanied by a robust growth in GFAP protein-positive satellite glial cells and activation of resident macrophages in the TG. Moreover, m-PEA administration significantly reduced the degree of TMJ damage and pain, macrophage activation in TG and up-regulation of Iba1.
CONCLUSIONS: The results confirm that m-PEA could represent a novel approach for monitoring pain during trigeminal nerve sensitization.

Entities:  

Keywords:  Glia; Inflammation; Micronization; Palmitoylethanolamide; Temporomandibular joint

Mesh:

Substances:

Year:  2018        PMID: 30121836     DOI: 10.1007/s00011-018-1179-y

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  37 in total

1.  Microglia produce and hydrolyze palmitoylethanolamide.

Authors:  Giulio G Muccioli; Nephi Stella
Journal:  Neuropharmacology       Date:  2007-06-02       Impact factor: 5.250

Review 2.  Peripheral and central mechanisms of orofacial inflammatory pain.

Authors:  Barry J Sessle
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

Review 3.  Degenerative Joint Diseases and Neuroinflammation.

Authors:  Mariella Fusco; Stephen D Skaper; Stefano Coaccioli; Giustino Varrassi; Antonella Paladini
Journal:  Pain Pract       Date:  2017-02-10       Impact factor: 3.183

Review 4.  Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

Authors:  Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; Sean C Mackey; John Mayer; Christine Miaskowski; Srinivasa N Raja; Andrew S C Rice; Kenneth E Schmader; Brett Stacey; Steven Stanos; Rolf-Detlef Treede; Dennis C Turk; Gary A Walco; Christopher D Wells
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

5.  Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells.

Authors:  S Cerrato; P Brazis; M F della Valle; A Miolo; A Puigdemont
Journal:  Vet Immunol Immunopathol       Date:  2009-06-27       Impact factor: 2.046

6.  Intraganglionic injection of a nitric oxide donator induces afferent mechanical sensitization that is attenuated by palmitoylethanolamide.

Authors:  Brian E Cairns; Jens C Laursen; Xu-Dong Dong; Parisa Gazerani
Journal:  Cephalalgia       Date:  2014-02-11       Impact factor: 6.292

Review 7.  Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.

Authors:  Stephen D Skaper; Laura Facci; Pietro Giusti
Journal:  Mol Neurobiol       Date:  2013-06-28       Impact factor: 5.590

Review 8.  Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges.

Authors:  Maryam Rahmati; Ali Mobasheri; Masoud Mozafari
Journal:  Bone       Date:  2016-01-23       Impact factor: 4.398

9.  Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain.

Authors:  Leonardo Guasti; Denise Richardson; Maulik Jhaveri; Khalil Eldeeb; David Barrett; Maurice R Elphick; Stephen P H Alexander; David Kendall; Gregory J Michael; Victoria Chapman
Journal:  Mol Pain       Date:  2009-07-01       Impact factor: 3.395

10.  Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain.

Authors:  Daniela Impellizzeri; Giuseppe Bruschetta; Marika Cordaro; Rosalia Crupi; Rosalba Siracusa; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  J Neuroinflammation       Date:  2014-08-28       Impact factor: 8.322

View more
  8 in total

Review 1.  Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update.

Authors:  Rosalba Siracusa; Rosanna Di Paola; Salvatore Cuzzocrea; Daniela Impellizzeri
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 2.  ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain.

Authors:  Ramona D'Amico; Daniela Impellizzeri; Salvatore Cuzzocrea; Rosanna Di Paola
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

3.  Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain.

Authors:  Marika Cordaro; Rosalba Siracusa; Daniela Impellizzeri; Ramona D' Amico; Alessio Filippo Peritore; Rosalia Crupi; Enrico Gugliandolo; Roberta Fusco; Rosanna Di Paola; Carlo Schievano; Salvatore Cuzzocrea
Journal:  Arthritis Res Ther       Date:  2019-11-28       Impact factor: 5.156

Review 4.  Glia and Orofacial Pain: Progress and Future Directions.

Authors:  Yi Ye; Elizabeth Salvo; Marcela Romero-Reyes; Simon Akerman; Emi Shimizu; Yoshifumi Kobayashi; Benoit Michot; Jennifer Gibbs
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

5.  Pharmacological Blockade of PPARα Exacerbates Inflammatory Pain-Related Impairment of Spatial Memory in Rats.

Authors:  Jessica C Gaspar; Catherine Healy; Mehnaz I Ferdousi; Michelle Roche; David P Finn
Journal:  Biomedicines       Date:  2021-05-27

Review 6.  An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events.

Authors:  Marika Cordaro; Salvatore Cuzzocrea; Rosalia Crupi
Journal:  Antioxidants (Basel)       Date:  2020-03-05

7.  3D Assessment of Endodontic Lesions with a Low-Dose CBCT Protocol.

Authors:  Marco Portelli; Angela Militi; Antonino Lo Giudice; Roberto Lo Giudice; Lorenzo Rustico; Rosamaria Fastuca; Riccardo Nucera
Journal:  Dent J (Basel)       Date:  2020-05-13

8.  The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats.

Authors:  Rosalba Siracusa; Roberta Fusco; Marika Cordaro; Alessio F Peritore; Ramona D'Amico; Enrico Gugliandolo; Rosalia Crupi; Tiziana Genovese; Maurizio Evangelista; Rosanna Di Paola; Salvatore Cuzzocrea; Daniela Impellizzeri
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.